Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins.Like ritonavir (Norvir), cobicistat is of interest for its ability to inhibit liver enzymes that metabolize other medications used to treat HIV, notably elvitegravir, an HIV integrase inhibitor. By combining cobicistat with elvitegravir, higher concentrations of the latter are achieved in the body with lower dosing, theoretically enhancing elvitegravirs viral suppression while diminishing its adverse side-effects. In contrast with ritonavir, the only other booster approved for use as a part of HAART, cobicistat has no anti-HIV activity of its own.Cobicistat is a component of three four-drug, fixed-dose combination HIV treatments. The first, elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil, is marketed as Stribild and was approved by the FDA in August 2012 for use in the United States. The second, elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide, is marketed as Genvoya and was approved by the FDA in November 2015 for use in the United States. Both Stribild and Genvoya are owned by Gilead Sciences. The third, cobicistat, darunavir, emtricitabine, and tenofovir alafenamide, is marketed as Symtuza and was FDA approved July 17, 2018 and is owned by Janssen Pharmaceuticals.Additionally, in existence are a fixed-dose combination of cobicistat and protease inhibitor darunavir (darunavir/cobicistat; marketed as Prezcobix by Janssen Therapeutics), and a fixed-dose combination of cobicistat and protease inhibitor atazanavir (atazanavir/cobicistat; marketed as Evotaz by Bristol-Myers Squibb). Both Prezcobix and Evotaz were approved by the FDA in January 2015.
In order to be diagnosed, an individual must have at least four of the following symptoms in a 12-month period:
Needs to gamble with increasing amounts of money in order to achieve the desired excitement
Is restless or irritable when attempting to cut down or stop gambling
Has made repeated unsuccessful efforts to control, cut back, or stop gambling
Is often preoccupied with gambling (e.g., having persistent thoughts of reliving past gambling experiences, handicapping or planning the next venture, thinking of ways to get money with which to gamble)
Often gambles when feeling distressed (e.g., helpless, guilty, anxious, depressed)
After losing money gambling, often returns another day to get even ("chasing" ones losses)
Lies to conceal the extent of involvement with gambling
Has jeopardized or lost a significant relationship, job, education, or career opportunity because of gambling
Relies on others to provide money to relieve desperate financial situations caused by gambling

Factors that lead to gambling addiction
Mayo Clinic specialists state that compulsive gambling may be result from biological, genetic, and environmental factors, such as:
mental health disorders (the presence of substance use disorders, personality disorders, emotional states)
age and sex (usually found in youth or middle-aged people, and more common to men than women)
impact on family or friends
personality traits
drugs with rare side-effects (for example, antipsychotic medications or dopamine agonists).Other studies add the following triggers to the mentioned above:
traumatic conditions
job-related stress
solitude
other addictionsIf not treated, problem gambling may cause very serious and lasting effects on an individuals life:
relationship related issues
problems with money, bankruptcy
legal problems, imprisonment
health problems
suicide, including suicidal thoughts and attempts

Suicide rates
A gambler who does not receive treatment for pathological gambling when in a desperation phase may contemplate suicide.